Dr. Carlos M. Guida, MD

  • Miami, FL
  • Hematologist and oncologist
NPI1205809670PAC ID2365578978
Medicare services, 2024
5,286
Medicare patients, 2024
994
Part D claims, 2024
126
Publications
2
MIPS score, 2024
75
Practice address
11750 Bird Rd, Miami, FL 33175
Practice phone
Call (305) 223-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

HCA Florida Kendall Hospital

Hospital · Miami, Florida

See all 6 affiliations

Find Dr. Guida's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Carlos M. Guida is a hematologist and oncologist in Miami, Florida

Dr. Guida practices at HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare.

Dr. Guida's NPI, 1205809670, was assigned on February 8, 2006. Dr. Guida graduated from Universidad de Ciencias Medicas in 1985. Dr. Guida holds Florida license ME56236.

NPI and contact details
Medicare PAC ID
2365578978
NPI enumeration date
February 8, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(305) 223-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
67
Medical school graduation
1985

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Carlos M. Guida practices at HCA Florida Kendall Hospital in Miami, Florida

Dr. Guida's primary practice is HCA Florida Kendall Hospital, at 11750 Bird Rd, Miami, FL 33175 in Miami-Dade County. The practice phone is (305) 223-3000.

Source: Dmand AI Affiliation Data

Dr. Carlos M. Guida is affiliated with 6 sites of care

Dr. Guida's primary practice is HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare. Dr. Guida is also affiliated with Baptist Health Baptist Hospital. Dmand AI also links Dr. Guida to 3 more hospitals and 1 physician office, each named with a free account. Dr. Guida's employer is on file too: a hospital.

See all 6 affiliations for Dr. Guida

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Carlos M. Guida's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Guida practices, 6 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
HCA Florida Kendall HospitalAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Guida practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across HCA Healthcare and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Carlos M. Guida is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Guida's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Guida is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Guida's licenses on file in 2 states: Florida and Pennsylvania.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME56236 · 1989 to 2027 · taxonomy 207RH0003X
  • Pennsylvania license1987 to 2000

Clinical focus

Dmand AI lists breast cancer, chronic anemia and deep vein thrombosis (DVT) among the conditions Dr. Guida treats.

Hematologists and oncologists near Dr. Guida

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Carlos M. Guida billed Medicare for 5,286 services in 2024

CMS data shows 5,286 Medicare services from Dr. Guida across 9 procedure codes in 2024, for 994 Medicare patients. Medicare paid $339,942 for them.

Medicare services, 20245,286
Medicare patients994
Paid by Medicare$339,942
Procedure codes9

Dr. Guida's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 4,9652024: 5,2866%

Where Dr. Guida's Medicare services took place, 2024

  • In an office852%
  • In a facility5,20198%

Dr. Guida compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Guida
  • Florida median
Medicare services
5,286vs 6977.6 times
Medicare patients
994vs 2184.6 times
Part D claims
61vs 34182% below

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Guida's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Guida

Need commercial claims for Dr. Guida?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Guida and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Carlos M. Guida treated 994 Medicare patients in 2024, average age 78

CMS counts 994 Medicare patients who saw Dr. Guida in 2024. The largest group is 75 to 84, with 362 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 76% are also on Medicaid. Their average risk score is 4.24, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Guida's median patient age at 73, with 52% women.

Medicare patients, 2024994
Average age78
Average risk score4.24
Also on Medicaid76%

Dr. Guida's Medicare patients by age, 2024

Dr. Guida's Medicare patients by sex, 2024

  • Women51051%
  • Men48449%

Chronic conditions among Dr. Guida's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Chronic kidney disease72%
  4. Mood disorders72%
  5. Diabetes70%
  6. Anxiety69%
  7. Depression68%
  8. Heart failure66%

Share of Medicare patients with each condition. A patient can have several.

Dr. Guida's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 73

Patient panel by sex, all payers

  • Women52%
  • Men48%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Carlos M. Guida wrote 126 Medicare Part D claims in 2024

In 2024, Dr. Guida wrote 126 Medicare Part D claims for 34 patients. 52% of them were for generic drugs. CMS names the drug for 61 of them, across 4 drugs with 11 or more claims each, at $45,807 in total drug cost. In 2023, CMS named 119 claims across 5 drugs.

Part D claims, 2024126
Drugs named by CMS4
Total drug cost$45,807
Part D patients34

Dr. Guida's Part D claims by kind of drug, 2024

  • Generic66 claims52%
  • Brand-name60 claims48%

Dr. Guida's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1192024: 6149%

Drugs named by CMS: 4 in 2024, 5 in 2023.

See all prescribing by Dr. Guida

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Carlos M. Guida scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Guida for performance year 2024, reported individually. Dr. Guida accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Guida as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Guida by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Carlos M. Guida has 2 publications on record

Dmand AI links 2 papers to Dr. Guida, published from 2021 to 2023. Dr. Guida's most frequent co-authors are Obteene Azimi-Ghomi, MD, Adrian Tomas Marimon, MD and Mark G. McKenney, MD.

Papers2
Years published2021 to 2023

Dr. Guida's most frequent co-authors

Recent publications by Dr. Guida

See all 2 publications and co-authors

See who Dr. Guida researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Guida works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Carlos M. Guida received $1,131 in industry payments from 2016 to 2025

CMS Open Payments shows 46 general payments to Dr. Guida from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Celgene Corporation paid the most, $271.

General payments to Dr. Guida by program year, 2016 to 2025

General payments to Dr. Guida by kind, 2016 to 2025

$1.1Kin total
  • Food and beverage$1,09997%
  • Education$323%

Companies that paid Dr. Guida the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Guida

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Carlos M. Guida graduated from Universidad de Ciencias Medicas

Dr. Guida graduated from Universidad de Ciencias Medicas in 1985.

  1. Medical schoolUniversidad de Ciencias Medicas
  2. Board certified in internal medicineAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Carlos M. Guida accepts plans from 4 insurance carriers

Dr. Guida is in network with 4 carriers, including United Healthcare, Elevance and Blue Cross and Blue Shield of Kansas City. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.

  • United Healthcare
  • Elevance
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare

Plan types Dr. Guida accepts, by number of carriers

  1. EPO2
  2. HMO2
  3. Medicare2
  4. PPO2
  5. POS1

Source: Dmand AI Insurance Network Data

Sources for Dr. Carlos M. Guida's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Carlos M. Guida

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Carlos M. Guida's NPI number?

Dr. Carlos M. Guida's NPI number is 1205809670. It was assigned on February 8, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Carlos M. Guida?

Dr. Carlos M. Guida is a hematologist and oncologist in Miami, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Carlos M. Guida practice?

Dr. Guida practices at 11750 Bird Rd, Miami, FL 33175. Dr. Guida's primary practice is HCA Florida Kendall Hospital in Miami, Florida, part of HCA Healthcare. Dmand AI also links Dr. Guida to 3 hospitals and 1 physician office.

What is Dr. Carlos M. Guida's office phone number?

The practice phone on file for Dr. Guida is (305) 223-3000.

What is Dr. Carlos M. Guida's medical license number?

Dr. Guida holds Florida license ME56236, one of the licenses on file in 2 states.

Which states has Dr. Carlos M. Guida been licensed in?

Dmand AI has state licenses on file for Dr. Guida in Florida (1989 to 2027) and Pennsylvania (1987 to 2000).

Which hospitals is Dr. Carlos M. Guida affiliated with?

Dr. Guida practices at HCA Florida Kendall Hospital in Miami, Florida. Dr. Guida is also affiliated with Baptist Health Baptist Hospital. Dmand AI links Dr. Guida to 3 more hospitals.

Does Dr. Carlos M. Guida accept Medicare?

Yes. CMS data shows Dr. Guida billed Medicare for 5,286 services in 2024, and Dr. Guida accepts Medicare assignment.

Does Dr. Carlos M. Guida offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Guida as offering telehealth services.

What is Dr. Carlos M. Guida's MIPS score?

Dr. Guida's MIPS final score for performance year 2024 is 75 out of 100, reported individually.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Carlos M. Guida see?

CMS counts 994 Medicare patients who saw Dr. Guida in 2024, with an average age of 78.

Is Dr. Carlos M. Guida board certified?

Yes. Dr. Guida is board certified in internal medicine by the American Board of Internal Medicine.

What services does Dr. Carlos M. Guida bill to Medicare?

In 2024, Dr. Guida's most billed Medicare services were hospital inpatient care (99232), hospital inpatient care (99231) and hospital inpatient care (99222).

Where did Dr. Carlos M. Guida go to medical school?

Dr. Guida graduated from Universidad de Ciencias Medicas in 1985.

What drugs does Dr. Carlos M. Guida prescribe most?

In 2024 Medicare Part D data, Dr. Guida's most prescribed drugs by claims were Hydroxyurea, Xarelto and Eliquis.

Has Dr. Carlos M. Guida received payments from drug or device companies?

CMS Open Payments shows $1,131 in general payments to Dr. Guida from 15 companies from 2016 to 2025. The largest total came from Celgene Corporation.

How long has Dr. Carlos M. Guida been practicing?

Dr. Guida graduated from medical school in 1985, 41 years ago.

Does Dr. Carlos M. Guida do research?

Dmand AI links 2 publications to Dr. Guida, published from 2021 to 2023.

Who does Dr. Carlos M. Guida publish with?

Dr. Guida's most frequent co-authors are Obteene Azimi-Ghomi, MD (1 shared paper), Adrian Tomas Marimon, MD (1 shared paper) and Mark G. McKenney, MD (1 shared paper).

What insurance does Dr. Carlos M. Guida accept?

Dr. Guida is in network with 4 carriers, including United Healthcare, Elevance and Blue Cross and Blue Shield of Kansas City. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)